StrongBox Wealth’s Takeda Pharmaceutical TAK Stock Holding History

StrongBox Wealth’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$346	Buy	+19	New	+$336	﹤0.01%	295

Other funds holding TAK

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Catalyst Capital Advisors Huntington, New York $6.21B AUM 15.35% 1-Year Est. Return

StrongBox Wealth's TAK Position: Q3 2026 in Review

StrongBox Wealth opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 19 shares worth $346. The stake represents ﹤0.01% of the portfolio and ranks #295 among its holdings.

175 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

StrongBox Wealth held 19 shares of Takeda Pharmaceutical worth $346 as of Q3 2026.
Takeda Pharmaceutical was a new StrongBox Wealth position in Q3 2026.
Takeda Pharmaceutical made up ﹤0.01% of StrongBox Wealth's portfolio in Q3 2026, its #295 holding.
175 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on StrongBox Wealth's 13F filing for Q3 2026, filed 2 Nov 2026.